Small Molecules & TPD World Series

The Small Molecules and TPD World Series is committed to delivering the most comprehensive collection of industry-dedicated forums, exclusively focusing on the specific challenges faced for each community of small molecules and protein degradation drug developers.

The goal for this event series is to provide your team with the platform to connect, learn and fast-track first-in-class or next generation of selective, orally bioavailable and clinically efficacious small molecules for undrugged or hard-to-drug targets to meet the needs of patients globally.

View the Small Molecules & TPD World Series conference calendar below. If you have any questions, get in touch at info@hansonwade.com.

Induced Proximity

Successfully Screen & Validate Novel Protein-Protein Inducing Mechanisms & Chemical Matters to Improve the Selectivity & Off-Target Effect of Your Degrader & Non-Degrader Proximity-Based Drugs from Discovery to Clinic

July 23-25, 2024 | Boston, MA

LEARN MORE

21516 6th RAS Targeted Drug Discovery Summit logo

Overcome Diverse Clinical Resistance Mechanisms with Emerging First- & Best-In-Class Combination & Monotherapies to Effectively Treat Patients with RAS-Driven Lung, Colorectal & Pancreatic Cancers

September 24-26, 2024 | Boston, MA

LEARN MORE

TPD US

Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address Unmet Need in Oncology & Beyond

October 29-31, 2024 | Boston, MA

LEARN MORE

GPCRs Targeted Drug Discovery Summit Europe

Leverage Advances in Structural Biology, Screening & Target Validation Whilst Overcoming Pharmacology Challenges to Successfully Translate Your Small Molecules & Biologics from Novel Discoveries to Clinically Relevant & Effective GPCR Drugs

26-28 November, 2024 | London, UK

LEARN MORE

Hippo-Pathway-Targeted-Drug-Development-Summit

Improve Selectivity, Reduce Toxicity & Overcome Limitations of Preclinical Models & Clinical Biomarkers to Accelerate Translation & Development of Hippo Pathway Targeted Therapeutics for Patients

November, 2024 | Virtual

 

LEARN MORE

Covalent Drug Discovery Development

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & Beyond

December 10-12, 2024 | Boston, MA

LEARN MORE

Molecular Glue Drug Development Summit

Accelerate the Discovery, Validation and Clinical Translation of Novel and Rationally Designed Molecular Glues through Systematic Screening, Expanding Ligase Toolbox and Optimizing Pharmacological Properties

Returning January, 2025 | Boston, MA

LEARN MORE

5th TPD Targeted Protein Degredation Summit Europe

Leverage Advances in Structural Biology, Screening & Target Validation Whilst Overcoming Pharmacology Challenges to Successfully Translate Your Small Molecules & Biologics from Novel Discoveries to Clinically Relevant & Effective GPCR Drugs 

Returning March, 2025 | London, UK

LEARN MORE

GPCRs-Targeted-Drug-Discovery-Summit

Harnessing the Power of Advanced Computing, Genomic & Structure-Based Technologies to Safely & Selectively Target GPCRs with Next Generation Small Molecules & Biologics in Oncology, Metabolic Disorders & Beyond

Returning 2025 | Boston, MA

LEARN MORE